This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Mario Pulido
Senior BioPharma Application Scientist at SCIEX


Dr. Mario A. Pulido, currently a senior biopharma applications scientist at SCIEX evaluates capillary electrophoresis workflows using the single-capillary PA 800 Plus system or the multi-capillary BioPhase 8800 system for continuous improvements of nucleic acid-based products like vaccines or gene-based therapy. Dr. Pulido dissertation studies on small-cell lung cancer for immunotherapy development at the Keck School of Medicine of the University of Southern California demonstrated that protein aggregation or misfolding driven by isopartylation, a highly immunogenic and protein damage-causing post-translational modification, triggers autoimmunity using in vivo models and patient samples. In summary, Dr. Pulido enjoys the translation of basic research for biotechnology improvements or optimization of promising medicines.

Agenda Sessions

  • Supporting the Development of Next-generation Nucleotide-based Therapeutics, including ASOs and mRNA, with High-resolution Analytical Techniques- ROOM 103